AGMB — AgomAb Therapeutics NV | XLV Holdings | StockAdder

(AGMB)

AgomAb Therapeutics NV

Live chart and latest AGMB stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

AGMB News

AgomAb Therapeutics (AGMB) wins US patent for AGMB-447

Apr 15, 2026 Yahoo Finance

AgomAb Therapeutics (AGMB) Wins U.S. Patent for AGMB-447

Apr 12, 2026 Stock Titan

Agomab locks in U.S. protection for lung disease drug through 2041

Mar 26, 2026 Gotrade

Agomab Therapeutics NV (AGMB) Stock Price Today & Analysis

Feb 7, 2026 CNN

symbol__ Stock Quote Price and Forecast

Jan 31, 2026 Seeking Alpha

AgomAb Therapeutics NV Readies US IPO On Early Promising Results (AGMB)

Jan 29, 2026 TradingView — Track All Markets

AGMB Stock Price and Chart — NASDAQ:AGMB

Jan 19, 2026 Investing.com

Agomab prices IPO at $16 per share, aims to raise $200 million

Feb 5, 2026 Stock Titan

Agomab Therapeutics (AGMB) director details sizable stock option grants

Mar 18, 2026 Smartkarma

AgomAb Therapeutics NV (AGMB): Biotech Selectivity on Display as AgomAb Trades Below IPO Price

Feb 7, 2026 Seeking Alpha

SpyGlass, Agomab to make Nasdaq debuts with a combined $350M offering

Feb 6, 2026 Benzinga

This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tue

Mar 3, 2026 Stock Titan

Agomab Therapeutics (AGMB) director reports 27,921-share stock option grant

Mar 18, 2026 Seeking Alpha

Belgian biopharma Agomab to raise up to $210M in U.S. IPO

Jan 29, 2026 Stock Titan

Director Colin Bond details AGMB stock option awards in Form 3